[ Price : $8.95]
FDA approves ViiV Healthcares Dovato (dolutegravir/lamivudine) for treating HIV-1 infection in adolescents with no antiretroviral ...[ Price : $8.95]
FDA accepts for review a Stealth BioTherapeutics NDA for elamipretide for treating Barth syndrome.[ Price : $8.95]
FDA clears a Spirair 510(k) for its SeptAlign system for treating nasal septal deviation.[ Price : $8.95]
FDA approves a supplemental BLA submitted by Janssen for Carvykti (ciltacabtagene autoleucel) to treat adults with relapsed or ref...[ Price : $8.95]
FDA sends Supernus Pharmaceuticals a second complete response letter on its NDA resubmission for the companys apomorphine infusion...[ Price : $8.95]
Federal Register notice: FDA requests nominations for voting members, excluding consumer and industry representatives, to serve on...[ Price : $8.95]
Federal Register notice: FDA announces a 6/6 public meeting entitled Financial Transparency and Efficiency of the Prescription Dru...[ Price : $8.95]
Federal Register notice: FDA determines that 24 listed drug products were not withdrawn from sale for reasons of safety or effecti...